eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Letters

Ethical and legal issues at the interface of complementary and conventional medicine

MJA 2004; 181 (10): 581-582

Vicki Kotsirilos,* Craig S Hassed†

* General Practitioner, 31 Dunstan Street, Clayton, Melbourne, VIC 3168. † Senior Lecturer, and Coordinator of Complementary Medicine Teaching, Department of General Practice, Monash University, Melbourne, VIC.
Vicki.kAToptusnet.com.au

To the Editor: The complementary and alternative medicine (CAM) series raised awareness and provided balanced and thoughtful debate. The article by Kerridge and McPhee in that series1 is no exception, but we would like to question their conclusion that “not only is it unclear whether a true integration of conventional and unconventional medicines is possible, but, more importantly, whether it is even desirable”. For a variety of reasons we believe that it is both possible and desirable.

There are increasing examples of situations in which medical practitioners can integrate ethical, evidence-based CAM into practice. Apart from the well-known and validated examples, such as Hypericum perforatum (St John’s wort) for depression, ginger for nausea in pregnancy, and Gingko biloba for intermittent claudication, there are other, less well known, but increasingly investigated, examples of CAM for common conditions. With quality information and a little training, these can be readily incorporated into medical practice.

To illustrate, Hippocrates was known to use the herb Vitex agnus-castus (chasteberry) for treating symptoms of premenstrual syndrome. Today we have a randomised controlled trial (RCT) to support its use.2 There are RCTs to support the use of Serenoa repens (saw palmetto) for symptomatic relief of benign prostatic hypertrophy,3 and good evidence is accumulating for the use of glucosamine for osteoarthritis4 and mindfulness meditation for preventing relapse in recurrent depression.5

With systematic reviews on these CAMs doctors should be informed about them. However, the resources for promoting them are minimal compared with those used to promote pharmaceuticals. Considering side-effect profiles and patient autonomy, why shouldn’t trained medical practitioners offer effective CAM remedies as first-line therapy instead of a pharmaceutical? To say these therapies should only belong to the realm of CAM practitioners would be to deprive the medical practitioner and patient of a wider choice of treatments.

Communication, holism, balance and individualised care are the hallmarks of quality general practice and do not just belong to CAM therapists. If orthodox medical practice is to remain current, evidence-based and relevant, general practitioners have no option but to integrate safe, validated and ethical forms of CAM into their practice. If they are not adequately trained in the relevant discipline they may wish to refer to an appropriately qualified CAM practitioner, although statistics indicate that GPs prefer to refer to GPs already trained in CAM.6

  1. Kerridge IH, McPhee JR. Ethical and legal issues at the interface of complementary and conventional medicine. Med J Aust 2004; 181: 164-166. <eMJA full text> <PubMed>
  2. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 2001; 322: 134-137. <PubMed>
  3. Carraro J, Raynaud J, Koch G. Comparison of phytotherapy (permixon) with finasteride in the treatment of BPH: a randomized international study of 1,098 patients. Prostate 1996; 29: 231-240. <PubMed>
  4. Grainger R, Cicuttini FM. Medical management of osteoarthritis of the knee and hip joints. Med J Aust 2004; 180: 232-236. <eMJA full text> <PubMed>
  5. Teasdale JD, Segal ZV, Williams JM, et al. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000; 68: 615-623. <PubMed>
  6. Pirotta M, Farish SJ, Kotsirilos V, Cohen MM. Characteristics of Victorian general practitioners who practise complementary therapies. Aust Fam Physician 2002; 31: 1133-1138. <PubMed>

Peter C Arnold

Former GP, PO Box 280, Edgecliff, Sydney, NSW 2027. peterATarnold.name

To the Editor: Although Kerridge and McPhee stress the need to find an evidence base (if there is any) for CAM, they nevertheless claim “medical practitioners and students no longer have any choice but to gain some knowledge about CAM and the interface between conventional and complementary medicine.”1

I suppose that archaeologists, geologists, palaeontologists and biologists now need to gain some knowledge about the interface between Darwinism and Creation Science. And our astronomers need some knowledge about the interface between astronomy and astrology.

Science, including effective medical care, is not advanced by pandering to unscientific consumerism about unproven theories, especially if it manages to get the law on its side. Galileo was persecuted for “his heretical view” that the earth revolved around the sun. Have we learnt nothing from his experience?

Competing interests: Member, Australian Skeptics.

  1. Kerridge IH, McPhee JR. Ethical and legal issues at the interface of complementary and conventional medicine. Med J Aust 2004; 181: 164-166. <eMJA full text>

Ian H Kerridge,* John R McPhee†

* Associate Professor of Bioethics, † Honorary Associate in Health Law, Centre for Values Ethics and the Law in Medicine, University of Sydney, Blackburn Building, Sydney, NSW 2006.
kerridgeATmed.usyd.edu.au

In reply: We agree with Kotsirilos and Hassed that there are many examples of successful integration of “proven” CAM into conventional medical practice. Our question, however, is whether it is possible to integrate CAM where its theoretical maxims and practices are incommensurate with allopathic medicine (eg, homoeopathy) and whether “integrative medicine” will ulti-mately fragment and diminish CAM, further isolate “non-evidence-based” CAM practi-tioners and make less visible those views of health and disease that are not consistent with modern medicine.1

It is misleading for Arnold to imply that there may be no evidence base for complementary and alternative medicines (CAMs). We suggest that medical practitioners should ask themselves not whether an “evidence base” exists, but what the existing evidence shows. The picture that emerges from a review of the literature is one of variable clinical efficacy. Thus, there is no evidence to support the use of chiropractic for childhood asthma,2 but there is good evidence that phytomedicines may reduce crises in sickle-cell disease,3 that cranberry juice may reduce the frequency of symptomatic urinary tract infections in women,4 and that horse chestnut seed extract is an efficacious treatment for chronic venous insufficiency.5 There is also clinically important evidence about harmful interactions, for example that St John’s Wort, garlic and ginseng may lower blood levels of warfarin.6

Medical practitioners should be critical and sceptical of all untested claims of therapeutic benefit. We suggest they acquaint themselves with evidence about risks and benefits of CAMs, particularly in their own area of practice. This is not pandering to anything. It is evidence-based practice. By the same token, use of CAM may reflect evidence-based decision-making by doctors and patients. It is simply divisive to dismiss it as “unscientific consumerism about unproven theories”, and it is foolish in any case to dismiss the latter. Medicine and science must compete with non-scientific perspectives in the public sphere, for the contest of ideas is never over in human history.

Ideological positions are black and white. Science prefers shades of grey. We have indeed learnt much from Galileo’s experience.

  1. Faass N. Integrating complementary medicine into health systems. Gaithersburg: Aspen Publications, 2001.
  2. Balon J, Aker PD, Crowther ER, et al. A comparison of active and simulated chiropractic manipulation as adjunctive treatment for childhood asthma. N Engl J Med 1998; 339: 1013-1020.
  3. Cordeiro N, Oniyangi O. Phytomedicines (medicines derived from plants) for sickle cell disease. Cochrane Database Systematic Rev 2004; 3: CD004448.
  4. Jepson RG, Milhaljevic L, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Systematic Rev 2004; 1: CD001321.
  5. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Systematic Rev 2004; 2: CD003230.
  6. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs. A systematic review. Drugs 2002; 61: 2163-2175.

©The Medical Journal of Australia 2004 www.mja.com.au ISSN: 0025-729X

Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA